Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulant
- 1 January 2011
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 105 (06) , 1060-1071
Abstract
This study was designed to develop a solid oral dosage form of deoxycholic acid (DOCA)-conjugated low-molecular-weight heparin (LMWH) and to evaluate its oral absorption, distribution, and metabolic stability for the prospect of providing an orally bioavailable LMWH. The LMWH derivative (LHD) was synthesised and then formulated with solubilisers and other pharmaceutical excipients to form a solid tablet. Its absorption and distribution after oral administration were evaluated in mice, rats, and monkeys. The in vitro metabolic stability of LHD was examined by liver microsome assays. More than 80% of LHD was released from the tablet within 60 minutes, guaranteeing rapid tablet disintegration after oral administration. Oral bioavailability of LHD in mice, rats and monkeys were 16.1 ± 3.0, 15.6 ± 6.1, and 15.8 ± 2.5%, respectively. After the oral administration of 131I-tyramine-LHD, most of the absorbed drug remained in the blood circulation and was eliminated mainly through the kidneys. LHD was hardly metabolised by the liver microsomes and showed a stable metabolic pattern similar to that of LMWH. In a rat thrombosis model, 10 mg/kg of orally administered LHD reduced thrombus formation by 60.8%, which was comparable to the antithrombotic effect of the subcutaneously injected LMWH (100 IU/ kg). Solid tablets of LHD exhibited high oral absorption and statistically significant therapeutic effects in preventing venous thromboembolism. Accordingly, LHD tablets are expected to satisfy the unmet medical need for an oral heparin-based anticoagulant as an alternative to injectable heparin and oral warfarin.Keywords
This publication has 47 references indexed in Scilit:
- Enhanced antithrombotic effects of unfractionated heparin in rats after repeated oral doses and its relationship to endothelial heparin concentrationBritish Journal of Pharmacology, 2008
- Heparin and low-molecular-weight heparinThrombosis and Haemostasis, 2008
- Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarctionThrombosis and Haemostasis, 2008
- Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human SubjectsThe Journal of Clinical Pharmacology, 2007
- A newly developed oral heparin derivative for deep vein thrombosis: Non-human primate studyJournal of Controlled Release, 2007
- Prevention effect of orally active heparin derivative on deep vein thrombosisThrombosis and Haemostasis, 2006
- Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonanceJournal of Pharmaceutical and Biomedical Analysis, 2005
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1982
- Oral administration of liposomally-entrapped heparin to beagle dogs.Chemical and Pharmaceutical Bulletin, 1982